EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Screening of BRCA1 and BRCA2 germline mutations in unselected triple‐negative breast cancer patients: A series from north of Morocco

Mohammed Mansouri, Touria Derkaoui, Joaira Bakkach, Ali Loudiyi, Naima Ghailani Nourouti, Amina Barakat, Jaime Martínez de Villarreal, Carlos Cortijo Bringas, Mohcine Bennani Mechita

Precision Medical Sciences · 2020

DOI: 10.1002/prm2.12009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Precision Medical Sciences, 2020. Verfasst von Mohammed Mansouri und 8 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Triple‐negative breast cancer (TNBC) is strongly associated with BRCA1 and BRCA2 germline pathogenic variants. Revised NCCN guidelines recommend that TNBC patients ≤60 years of age should be referred for genetic counseling and consideration of BRCA1/2 testing. The aim of the present study is to characterize germline BRCA1 and BRCA2 variants in a series of TNBC patients from the north of Morocco.

Methods

We analyzed BRCA1 and BRCA2 genes by next generation sequencing in a cohort of 32 patients unselected for family history and age of diagnosis.

Results

Among 32 patients with TNBC, 7 carried a pathogenic BRCA1 or BRCA2 variant (21.87%). Six patients carried a pathogenic BRCA1 variant and one carried a pathogenic BRCA2 variant. Overall, six different pathogenic BRCA1 or BRCA2 variants were identified, including frameshift, nonsense, and missense variants. The BRCA1 missense c.5309G>T, a founder pathogenic variant in the Moroccan population, was identified in two unrelated patients. In addition, six variants of unknown clinical significance were identified.

Conclusions

The understanding of BRCA1 and BRCA2 status in TNBC patients plays an important role in optimizing the preventive and therapeutic management. Despite the small size of our cohort, we believe that this work would help broaden our knowledge of TNBC and BRCA1/2 variants in Morocco.

Zitieren

APA

Mansouri, M., Derkaoui, T., Bakkach, J., Loudiyi, A., Nourouti, N. G., Barakat, A., Villarreal, J. M. D., Bringas, C. C., & Mechita, M. B. (2020). Screening of BRCA1 and BRCA2 germline mutations in unselected triple‐negative breast cancer patients: A series from north of Morocco. Precision Medical Sciences. https://doi.org/10.1002/prm2.12009

Vancouver

Mansouri M, Derkaoui T, Bakkach J, Loudiyi A, Nourouti NG, Barakat A, et al. Screening of BRCA1 and BRCA2 germline mutations in unselected triple‐negative breast cancer patients: A series from north of Morocco. Precision Medical Sciences. 2020. doi:10.1002/prm2.12009

BibTeX
@article{Mansouri2020,
  author = {Mansouri, Mohammed and Derkaoui, Touria and Bakkach, Joaira and Loudiyi, Ali and Nourouti, Naima Ghailani and Barakat, Amina and Villarreal, Jaime Martínez de and Bringas, Carlos Cortijo and Mechita, Mohcine Bennani},
  title = {Screening of BRCA1 and BRCA2 germline mutations in unselected triple‐negative breast cancer patients: A series from north of Morocco},
  journal = {Precision Medical Sciences},
  year = {2020},
  doi = {10.1002/prm2.12009}
}
Kostenlos starten →